Application 203139
- Type
- ANDA
- Sponsor
- TWI PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | MEGESTROL ACETATE | MEGESTROL ACETATE | SUSPENSION;ORAL | 125MG/ML | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 24979-041 | Megestrol Acetate | Megestrol Acetate | TWi Pharmaceuticals, Inc. | ANDA | Current |
| 24979-041 | Megestrol Acetate | Megestrol Acetate | TWi Pharmaceuticals, Inc. | ANDA | Current |
| 71205-943 | Megestrol Acetate | Megestrol Acetate | Proficient Rx LP | ANDA | Current |
| 71205-943 | Megestrol Acetate | Megestrol Acetate | Proficient Rx LP | ANDA | Current |